🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs
5,568

Quick answer

Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Page 110 of 116

  1. rSIFN-co

    Sichuan Provincial People's Hospital

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule completed

    1 trial

  2. selinexor

    Karyopharm Therapeutics Inc

    B-cell Lymphoma

    phase 1 small molecule completed

    1 trial

  3. selinexor

    Karyopharm Therapeutics Inc

    Recurrent Melanoma

    phase 1 small molecule completed

    1 trial

  4. sphingosine kinase-2 inhibitor ABC294640

    Apogee Therapeutics

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  5. standard chemotherapy medicine combined with Chinese herbs

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule active

    1 trial

  6. standard dose capecitabine

    Karyopharm Therapeutics Inc

    Rectal Neoplasms

    phase 1 small molecule active

    1 trial

  7. uCD7 CART

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia (AML)

    phase 1 mab active

    1 trial

  8. universal CLL1 CAR-T cells

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  9. veliparib

    BRIGHT MINDS BIOSCIENCES INC.

    Small Cell Lung Cancer SCLC

    phase 1 small molecule active

    1 trial

  10. zanzalintinib

    Arcus Biosciences

    Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  11. ziftomenib

    Kura Oncology

    Gastrointestinal Stromal Tumor (GIST)

    phase 1 small molecule active

    1 trial

  12. zimberelimab

    Arcus Biosciences

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  13. ziv-aflibercept

    Regeneron UK Limited

    Lymphoma

    phase 1 mab completed

    2 trials

  14. ziv-aflibercept

    Regeneron UK Limited

    Cancer

    phase 1 mab completed

    2 trials

  15. α-lactalbumin vaccine

    Anixa Biosciences Inc

    Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer

    phase 1 mab active

    1 trial

  16. γδT Cell infusion agent

    The First People's Hospital of Lianyungang

    Leukemia, B-cell

    phase 1 small molecule active

    1 trial

  17. ​​AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors ​

    Amgen

    microsatellite instability high/mismatch repair deficient (MSI-H/dMMR) solid tumors

    phase 1 other active

    1 trial

  18. „INSIGHT“ An explorative, open-labeled, phase I trial to evaluate feasibility and safety of eftilagimod alpha (IMP321, a LAG-3Ig fusion protein acting as LAG-3 agonist) in combination with immunotherapeutic, targeted or chemotherapeutic agents or when administered via new routes of application in advanced stage solid tumors

    The George Institute

    Histologically confirmed locally advanced or metastatic solid tumor (Strata A, B, D): Specification for Stratum C: Only patients with NSCLC adenocarcinomas, (squamous or adenosquamous not permitted) who are scheduled to receive platin + pembrolizumab + pemetrexed standard treatment (only for Stratum C) Specification for Stratum E: Including only metastatic or irresectable locally advanced urothelial carcinomas (only for Stratum E)

    phase 1 other active

    1 trial

  19. 1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

    Takeda

    Prostate or Bladder Cancer

    approved small molecule completed

    1 trial

  20. 99mTc-Macro Albumin Aggregate

    BRIGHT MINDS BIOSCIENCES INC.

    Carcinoma

    approved small molecule completed

    1 trial

  21. ATRA+Arsenic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukemia

    approved small molecule active

    1 trial

  22. Abemaciclib

    Eli Lilly and Company

    Metastatic Breast Cancer

    approved small molecule terminated

    1 trial

  23. Abemaciclib

    Eli Lilly and Company

    Breast Neoplasms

    approved small molecule completed

    1 trial

  24. Academic Detailing

    United Therapeutics Europe Ltd

    Prostate Cancer

    approved other terminated

    1 trial

  25. Afatinib

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  26. Alecensa 150 mg hard capsules

    Disc Medicine

    ALK positive non-small cell lung cancer

    approved small molecule active

    1 trial

  27. Atezolizumab

    Hoffmann-La Roche

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  28. Avastin 25 mg/ml concentrate for solution for infusion., KEYTRUDA 25 mg/mL concentrate for solution for infusion.

    Disc Medicine

    Metastatic cervical cancer

    approved small molecule active

    1 trial

  29. Babaodan oral capsule

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved small molecule active

    1 trial

  30. Bavencio 20 mg/mL concentrate for solution for infusion

    Disc Medicine

    urothelial cancer, Bladder cancer, muscle invasive bladder cancer

    approved small molecule active

    1 trial

  31. Blinatumomab

    The First People's Hospital of Lianyungang

    Acute B-cell Lymphoblastic Leukemia

    approved small molecule active

    1 trial

  32. Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib

    Pfizer Australia Pty Ltd

    Solid tumors

    approved small molecule active

    1 trial

  33. Brentuximab vedotin

    Takeda

    T-Cell Lymphoma

    approved small molecule completed

    1 trial

  34. Brentuximab vedotin

    Takeda

    Lymphoma

    approved small molecule active

    2 trials

  35. Brucea javanica oil emulsion injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved other active

    1 trial

  36. CAPECITABINE, CALCIUM FOLINATE, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Calciumfolinat Kabi 10 mg/ml Injektions-/Infusionslösung, FLUOROURACIL, Lenvatinib, Lenvatinib, Calciumfolinat-GRY® 100 mg/10 ml Injektionslösung, OXALIPLATIN, Lenvatinib, CALCIUM LEVOFOLINATE , CAPECITABINE

    Merck Sharp and Dohme

    Advanced/Metastatic Gastroesophageal Adenocarcinoma

    approved small molecule active

    1 trial

  37. CARBOPLATIN, PACLITAXEL, DOCETAXEL, VINORELBINE TARTRATE, CISPLATIN, PEMETREXED

    CERO THERAPEUTICS HOLDINGS, INC.

    Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)

    approved small molecule active

    1 trial

  38. CERITINIB

    Novartis Pharmaceuticals

    non small cell lung cancer

    approved small molecule active

    1 trial

  39. CHLORURE DE SODIUM 0,9 % VIAFLO, solution pour perfusion, Avastin 25 mg/ml concentrate for solution for infusion.

    Tour Hekla

    1st line treatment for unresectable metastatic colorectal cancer

    approved small molecule active

    1 trial

  40. COBICISTAT , OLAPARIB

    Disc Medicine

    Cancer

    approved small molecule active

    1 trial

  41. Camrelizumab + chemotherapy+Thalidomide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved small molecule active

    1 trial

  42. Chemoembolization and Response-Dependent Resection

    The First People's Hospital of Lianyungang

    Resectable Hepatocellular Carcinoma Beyond Milan Criteria

    approved other active

    1 trial

  43. Chlorhexidine gluconate

    Hospital Authority, Hong Kong

    Liver Tumors

    approved small molecule completed

    1 trial

  44. Cinobufacini injection

    The First People's Hospital of Lianyungang

    Liver Cancer

    approved small molecule active

    1 trial

  45. Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Locally advanced head and neck squamous cell carcinoma

    approved small molecule active

    1 trial

  46. Clensia polvo para solución oral., CitraFleet Polvo para solución oral en sobre

    The George Institute

    colorectal cancer early detection

    approved small molecule active

    1 trial

  47. Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses

    The First People's Hospital of Lianyungang

    HER2 Positive Breast Cancer

    approved small molecule active

    1 trial

  48. Cytokine-induced killer cells+ FOLFOX4

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved small molecule completed

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.